Efficacy of Unstable Shoes for Instability and Lumbopelvic Pain

NCT ID: NCT03065270

Last Updated: 2017-02-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-09-30

Study Completion Date

2015-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

During pregnancy, pregnant women adopt an atypical pattern position with the intention to maintain stability and balance.These postural changes can cause instability at the level of the sacroiliac joint with painful condition during pregnancy and postpartum.

40 % of women have postpartum lumbopelvic instability. In 17 % of cases the lumbopelvic pain is perpetuated.

Another alteration influenced by the gestational status and progress of labor is urinary incontinence (UI).

The mechanism developed by Masai Barefoot Technology (MBT) provides an unstable base. Some studies reviewed, indicate that this shoe increases muscle activity, contributes to the decrease of joint overload and thereby, decreases pain.

Objective To compare the efficacy of shoes with unstable sole MBT®, over the use of conventional sports shoes, in primiparous women with lumbopelvic postpartum pain.

Material and Methods Randomized clinical trial. 24 postpartum women from the Gynecology Service of the Hospital Universitario Madrid Chiron were included in the study.

The subjects were randomly divided into experimental and control group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lumbopelvic Postpartum Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A group

Group Type EXPERIMENTAL

Use unstable shoes Masai Barefoot Technology (MBT)

Intervention Type OTHER

Use of unstable shoes during 9 weeks, at least four hours per day.

B group

Group Type EXPERIMENTAL

Use conventional sport shoes

Intervention Type OTHER

Use of conventional sport shoes during 9 weeks, at least four hours per day.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Use unstable shoes Masai Barefoot Technology (MBT)

Use of unstable shoes during 9 weeks, at least four hours per day.

Intervention Type OTHER

Use conventional sport shoes

Use of conventional sport shoes during 9 weeks, at least four hours per day.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Primparous women.

* Postpartum, between 8-12 weeks after the date of delivery.
* With lumbopelvic pain and positive diagnostic tests of sacroiliac pain
* Women with ambulation ability.

Exclusion Criteria

* Presence of vaginal prolapses.
* Be receiving another treatment for the alteration that concerns us, pharmacological or any other type of therapy.
* Neuromuscular alterations.
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad Europea de Madrid

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Raquel Díaz-Meco Conde

Principal Investigador

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Raquel Diaz-Meco Conde, Doctor

Role: PRINCIPAL_INVESTIGATOR

Universidad Europea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UEM-DOL-2011-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.